Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ABGENIX INC (ABGX)
|
Add to portfolio |
|
|
|
| Price: |
$22.38
| | Metrics |
| OS: |
92.0
|
M
| |
-56
|
% ROE
|
| Market cap: |
$2.06
|
B
| |
-23
|
% ROIC
|
|
Net debt:
|
$117
|
M
| |
|
|
|
EV:
|
$2.18
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($189)
|
M
| |
|
|
| EPS |
($2.31)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 | Dec-31-01 | Dec-31-00 | Dec-31-99 |
| Revenues | 18.3 | 17.4 | 13.0 | 19.3 | 34.1 | 59.4 | 15.3 |
| Revenue growth | 5.2% | 34.1% | -32.5% | -43.4% | -42.7% | 287.8% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 18.3 | 17.4 | 13.0 | 19.3 | 34.1 | 59.4 | 15.3 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 137.0 | 124.4 | 94.3 | 128.5 | 96.2 | 50.1 | 21.1 |
| General and administrative | 22.3 | 27.3 | 30.2 | 31.6 | 19.4 | 8.9 | 5.2 |
| EBITA | -188.9 | -185.6 | -192.6 | -148.1 | -87.6 | -3.1 | -18.5 |
| EBITA margin | -1029.5% | -1063.9% | -1480.1% | -767.5% | -257.1% | -5.2% | -120.8% |
| Amortization of intangibles | | | | | 2.5 | 0.4 | |
| EBIT | -188.9 | -185.6 | -192.6 | -148.1 | -90.1 | -3.5 | -18.5 |
| EBIT margin | -1029.5% | -1063.9% | -1480.1% | -767.5% | -264.6% | -6.0% | -120.8% |
| Pre-tax income | -207.0 | -187.5 | -196.3 | -208.9 | -60.9 | -8.8 | -19.5 |
| Income taxes | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 1.0 |
| Tax rate | 0.0% | 0.0% | | 0.0% | 0.0% | 0.0% | |
| Net income | -207.0 | -187.5 | -196.4 | -208.9 | -60.9 | -8.8 | -20.5 |
| Net margin | -1128.1% | -1074.6% | -1509.4% | -1082.8% | -178.7% | -14.8% | -133.7% |
| |
| Diluted EPS | ($2.30) | ($2.11) | ($2.23) | ($2.39) | ($0.71) | ($0.11) | ($0.35) |
| Shares outstanding (diluted) | 89.9 | 88.7 | 87.9 | 87.2 | 86.1 | 80.1 | 58.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|